Categories: NewsPharmaceutical

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that it has granted equity inducement awards to three new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on December 15, 2022, in accordance with Nasdaq Listing Rule 5635(c)(4).

In the aggregate, the new non-executive employees received options to purchase 60,000 shares of Terns common stock and 30,000 restricted stock units (“RSUs”) for shares of Terns common stock. The options have an exercise price per share equal to $6.82, which was the closing price of Terns’ common stock on December 15, 2022, the date of grant. The options and RSUs vest over four years, subject to continued service through the applicable vesting dates.

About Terns

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH. Terns’ pipeline includes four clinical stage development programs including an allosteric BCR-ABL inhibitor, a THR-β agonist, an FXR agonist, a VAP-1 inhibitor, and a preclinical small-molecule GLP-1 receptor agonist program.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com

Staff

Recent Posts

NextStep Arthropedix to Launch TheRay™ Hip System

NextStep Arthropedix, a growing orthopedics company, announces the launch of TheRay™ Collared and Collarless Hip System.…

6 hours ago

SPS Health Acquires Mideast Delivery Solutions to Enhance Healthcare Delivery Network

MILWAUKEE, WI / ACCESSWIRE / July 15, 2024 / SPS Health, a leading innovator in…

6 hours ago

Avant Brands Reports Continued Growth in Q2 2024 Financial Results

Record Gross Revenue: Generated $9.4 million in gross revenue, establishing a new company record.Strong International…

6 hours ago

NHI Announces Second Quarter 2024 Earnings Release and Conference Call Date

MURFREESBORO, TN / ACCESSWIRE / July 15, 2024 / National Health Investors, Inc. (NYSE:NHI) announced…

6 hours ago

B2B Pharmacy Services Now Available from Canada Pharmacy

Established Canadian online pharmacy now partnering with smaller pharmaciesVICTORIA, BC / ACCESSWIRE / July 15,…

6 hours ago